NIH-funded research U01 cooperative agreement

Chronic Pancreatitis Clinical Research Cohort and Biorepository

Official title: The Chronic Pancreatitis Clinical Research Consortium

Funded at University of Florida · NIH-11408761 · Data updated 2026-11-12

A long-term study at UF/Advent Health following adults with acute, relapsing, and chronic pancreatitis to build a detailed group with biospecimens and data for better diagnosis and personalized care.

More Pancreatitis research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startSeptember 1, 2025
Project endJune 30, 2030
Funding year2026
Award (this year)$404,327
NIH project number5U01DK144420-02
Project IDNIH-11408761 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21 years and older with acute, relapsing acute, or chronic pancreatitis who are part of the PROCEED cohort or eligible for enrollment at participating sites.

Less likely to help

Patients not belonging to the PROCEED cohort or not undergoing pancreatitis-related care may not directly benefit from this repository-driven study.

What this research studies

This project continues the PROCEED cohort to recruit and monitor adults with acute, relapsing acute, and chronic pancreatitis. Researchers will collect blood, pancreatic and duodenal juice, urine, stool, saliva, and, when possible, pancreatic tissue, plus imaging and clinical data, to create a richly annotated biospecimen repository. The goal is to identify biomarkers that help with risk prediction, early diagnosis, prognosis, and tailoring treatments to individual patients. The work is designed to enable future studies on mechanisms and therapies to reduce pain, prevent relapses, and address related complications. Participation would involve periodic follow-up visits and providing samples as part of ongoing care at UF and affiliate sites.

Why it matters

Potential benefit: If successful, patients could benefit from earlier and more accurate diagnosis, better risk stratification, and more personalized treatment strategies for pancreatitis and its sequelae.

How similar studies have gone: Previous pancreatitis cohorts and biorepositories have advanced biomarker discovery and risk modeling, supporting the potential for meaningful findings in this approach.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Forsmark, Christopher E — University of Florida
  • Study coordinator: Forsmark, Christopher E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.